Mylan, Hospira recall injectable drugs over potentially dangerous particulate matter

Mylan and Hospira issued recalls for injectable medications after potentially dangerous particulate matter was discovered in the vials.

Mylan is recalling two lots of levoleucovorin injection, a chemotherapy drug, because copper salts were found in the samples during a 12-month stability testing.

Pfizer's Hospira plant is recalling three lots of a sodium bicarbonate injection after glass particles were discovered in some vials.

Neither company has received reports of adverse events related to the recall.

"Administration of a sterile injectable that has foreign particulates has the potential of severe health consequences," Mylan said in the recall notice.

Both companies have notified their direct customers.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Whitepapers

Featured Webinars